Go to content
UR Home

Niclosamide, but not ivermectin, inhibits anoctamin 1 and 6 and attenuates inflammation of the respiratory tract

URN to cite this document:
DOI to cite this document:
Ousingsawat, Jiraporn ; Centeio, Raquel ; Schreiber, Rainer ; Kunzelmann, Karl
[img]License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 22 Nov 2023 08:58

This publication is part of the DEAL contract with Springer.


Inflammatory airway diseases like cystic fibrosis, asthma and COVID-19 are characterized by high levels of pulmonary cytokines. Two well-established antiparasitic drugs, niclosamide and ivermectin, are intensively discussed for the treatment of viral inflammatory airway infections. Here, we examined these repurposed drugs with respect to their anti-inflammatory effects in airways in vivo and in ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons